216 related articles for article (PubMed ID: 24845687)
1. Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia.
Dossabhoy NR; Turley S; Gascoyne R; Tapolyai M; Sulaiman K
Ren Fail; 2014 Aug; 36(7):1033-7. PubMed ID: 24845687
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
[TBL] [Abstract][Full Text] [Related]
3. Accelerated total dose infusion of low molecular weight iron dextran is safe and efficacious in chronic kidney disease patients.
Sinha S; Chiu D; Peebles G; Swoboda P; Kolakkat S; Lamerton E; Fenwick S; Bhandari S; Kalra PA
QJM; 2011 Mar; 104(3):221-30. PubMed ID: 20956457
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.
Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M
Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041
[TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness of ferumoxytol in hemodialysis patients at 3 dialysis chains in the United States over a 12-month period.
Schiller B; Bhat P; Sharma A
Clin Ther; 2014 Jan; 36(1):70-83. PubMed ID: 24315802
[TBL] [Abstract][Full Text] [Related]
6. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy.
Ayub R; Tariq N; Adil MM; Iqbal M; Junaid A; Jaferry T
J Coll Physicians Surg Pak; 2008 Jul; 18(7):424-7. PubMed ID: 18760066
[TBL] [Abstract][Full Text] [Related]
8. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
Plummer ES; Crary SE; McCavit TL; Buchanan GR
Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of iron deficiency in predialysis state by low molecular weight iron dextran high doses intravenously].
Fievet P; Coppin M; Brazier F; Lefèvre M; Stephan R; Demontis R
Nephrol Ther; 2012 Feb; 8(1):41-6. PubMed ID: 21684231
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin plus health education versus total dose infusion (TDI) of low-molecular weight (LMW) iron dextran for treating iron deficiency anemia (IDA) in pregnancy: a randomized controlled trial.
Darwish AM; Fouly HA; Saied WH; Farah E
J Matern Fetal Neonatal Med; 2019 Jul; 32(13):2214-2220. PubMed ID: 29338568
[TBL] [Abstract][Full Text] [Related]
11. Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients.
Atalay H; Solak Y; Acar K; Govec N; Turk S
Hemodial Int; 2011 Jul; 15(3):374-8. PubMed ID: 21564503
[TBL] [Abstract][Full Text] [Related]
12. Use of intravenous iron supplementation in chronic kidney disease: an update.
Macdougall IC; Geisser P
Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis].
Ficheux M; Cuny P; Lecouf A; Ryckelynck JP; Hurault de Ligny B; Lobbedez T
Nephrol Ther; 2011 Dec; 7(7):558-61. PubMed ID: 21715234
[TBL] [Abstract][Full Text] [Related]
14. [Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients].
Reynoso-Gómez E; Salinas-Rojas V; Lazo-Langner A
Rev Invest Clin; 2002; 54(1):12-20. PubMed ID: 11995402
[TBL] [Abstract][Full Text] [Related]
15. Iron status and benefit of the use of parenteral iron therapy in pre-dialysis Chronic Kidney disease patients.
Arogundade FA; Soyinka FO; Sanusi AA; Ojo OE; Akinsola A
Niger Postgrad Med J; 2013 Dec; 20(4):299-304. PubMed ID: 24633272
[TBL] [Abstract][Full Text] [Related]
16. Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: a randomized controlled trial.
Tariq N; Ayub R; Khan WU; Ijaz S; Alam AY
J Coll Physicians Surg Pak; 2015 Mar; 25(3):193-7. PubMed ID: 25772960
[TBL] [Abstract][Full Text] [Related]
17. The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease.
Hood SA; O'Brien M; Higgins R
Nephrol Nurs J; 2000 Feb; 27(1):41-2. PubMed ID: 10852689
[TBL] [Abstract][Full Text] [Related]
18. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
Bhandari S; Naudeer S
J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
[TBL] [Abstract][Full Text] [Related]
19. Intravenous iron replacement for persistent iron deficiency anemia after Roux-en-Y gastric bypass.
DeFilipp Z; Lister J; Gagné D; Shadduck RK; Prendergast L; Kennedy M
Surg Obes Relat Dis; 2013; 9(1):129-32. PubMed ID: 22867554
[TBL] [Abstract][Full Text] [Related]
20. Comparative rates of adverse events with different formulations of intravenous iron.
Okam MM; Mandell E; Hevelone N; Wentz R; Ross A; Abel GA
Am J Hematol; 2012 Nov; 87(11):E123-4. PubMed ID: 22965928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]